Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04944576
Other study ID # 2018-42
Secondary ID 2020-A03401-38
Status Active, not recruiting
Phase
First received
Last updated
Start date September 14, 2021
Est. completion date September 13, 2029

Study information

Verified date May 2024
Source FH ORTHO
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is a post-market clinical follow-up conducted in order to collect long-term data on safety and performance of the EasyMove prosthesis, which is intended to be implanted in case of total ankle replacement, when used in real life conditions according to the instructions for use.


Description:

The primary objective is to evaluate the safety of the total ankle prosthesis, EasyMove, up to five years of follow-up. The secondary objectives are to evaluate both the safety and the performance of the total ankle prosthesis, EasyMove, up to five years of follow-up.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 82
Est. completion date September 13, 2029
Est. primary completion date September 13, 2029
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient implanted with the studied device according to the instructions for use, for primary surgery in patients with ankle joints damaged by severe rheumatoid, post-traumatic or degenerative arthritis - Adult patient (=18 years old) - Patient who received an information form and is willing to participate in the study Exclusion Criteria: - Contraindications listed in the instructions for use - Patient who is not able to express his/her non opposition

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Total Ankle Prosthesis, EasyMove®
Patients who will be implanted with a total ankle prosthesis, EasyMove.

Locations

Country Name City State
France Chu Brest Brest
France CH Raymond-Poincaré Garches
France Centre Hospitalier Départemental Vendée La Roche-sur-yon
France Clinique Jouvenet Paris
France Clinique Victor HUGO Paris
Switzerland Centre hospitalier universitaire vaudois Lausanne

Sponsors (1)

Lead Sponsor Collaborator
FH ORTHO

Countries where clinical trial is conducted

France,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Revision rate Revision rate of the implant for aseptic loosening. Up to 5 years of follow-up
Secondary Functional outcomes evaluation such as pain and mobility Functional ouctomes will be evaluated through the AOFAS score. This score is comprised of nine questions covering three categories: pain (40 points), function (50 points) and alignment (10 points). These are all scored together for a total of 100 points. The higher the score, the better the patient outcome. AOFAS is a clinician reporting tool that required both patient and provider participation to be fully complete. The AOFAS score will be compared to its MCID at each follow-up visit. The MCID will be calculated based on the distribution-based MCID method. preop, 4-6 weeks postop, 1 year postop, 2 years postop, 5 years postop
Secondary Functional outcomes evaluation such as mobility Functional ouctomes will be evaluated through the FAAM score. This score is a 29-item questionnaire divided into two subscales: 21-item Activities of Daily Living Subscale and 8-item Sports Subscale. Item score totals, which range from 0 to 84 for the Activities of Daily Living subscale and 0 to 32 for the Sports subscale, are transformed to percentage scores. The higher the score, the better the patient outcomes. It is a self-report outcome instrument. The FAAM score will be compared to its MCID at each follow-up visit. The Minimal Clinically Important Difference (MCID) of the Foot and Ankle Ability Measure (FAAM) at 1 year of follow-up compared to the theorical MCID retrieved in the literature (MCID = 31.2 (sd=25.3, superiority comparison)). For the following follow-up, the MCID will be calculated based on the distribution-based MCID method. preop, 1 year postop, 2 years postop, 5 years postop
Secondary Functional outcomes evaluation such as mobility Functional ouctomes will be evaluated through clinical data such as the range of motion. preop, 4-6 weeks postop, 1 year postop, 2 years postop, 5 years postop
Secondary Health status outcomes evaluation such as pain Health status outcomes will be evaluated through a visual analogue scale to measure pain. preop, 4-6 weeks postop, 1 year postop, 2 years postop, 5 years postop
Secondary Health status outcomes evaluation such as quality of life Health status outcomes will be evaluated through the SF-12 questionnaire to measure the quality of life. It is a self-reported outcome measure, composed of 12 questions. It provides an eight-scale profile of functional health and wellbeing, as well as two psychometrically based physical and mental health summary measures, scored on a T-score metric. The higher the score, the better the patient outcomes. The SF-12 score will be compared to its MCID at each follow-up visit. The MCID will be calculated based on the distribution-based MCID method. preop, 1 year postop, 2 years postop, 5 years postop
Secondary Radiological data evaluation Radiological data results such as the postion of the implant, lucency, calcification will be evaluated. preop, 4-6 weeks postop, 1 year postop, 2 years postop, 5 years postop
Secondary Rate of complications All complications will be gathered from the intervention up to 5 years of follow-up. perop, 4-6 weeks postop, 1 year postop, 2 years postop, 5 years postop
See also
  Status Clinical Trial Phase
Completed NCT03262324 - The Aim of Study is Translate and Adapt the Visual Analog Scale Foot and Ankle (VAS-FA) Instrument Into Turkish and Psycho-metrically Test Its Reliability and Validity Among Patients Who Had Foot and Ankle Disorders or Surgery
Active, not recruiting NCT04390048 - Balance Training With tDCS for CAI N/A
Completed NCT06125158 - Effects of Hip Strength Training and Neuromuscular Electrical Stimulation on Functional Ankle Instability N/A
Completed NCT05500131 - The Association Between Restricted Ankle Joint Dorsiflexion and Dynamic Knee Valgus
Withdrawn NCT03309098 - Agreement Between Clinician and Instrumented Laxity Assessment
Completed NCT05847972 - Effect of Manual Therapy and Inmediately Application of Plantar Orthoses N/A
Recruiting NCT05494645 - Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery: A Randomized Controlled Trial Phase 4
Completed NCT04699396 - The Immediate Effect of Mobilisation With Movement in Amateur Futsal Athletes With Chronic Ankle Instability N/A
Completed NCT03415464 - Prevention of Musculoskeletal Injuries in Slovenian Armed Forces N/A
Recruiting NCT06233565 - Dexamethasone vs. Dexmedetomidine for Popliteal Nerve Block in Pain Management After Pediatric Ankle and Foot Surgery Phase 4
Not yet recruiting NCT06304324 - Dexmedetomidine vs Dexamethasone in Popliteal Nerve Block Phase 4
Recruiting NCT05662449 - A Cohort Study of Bioabsorbable Screws for Syndesmosis Fixation Fixation in Ankle Fracture